Chardan Capital reaffirmed their buy rating on shares of REGENXBIO (NASDAQ:RGNX – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. They currently have a $52.00 ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant ...

Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines. Here's what investors need to know about this small-cap biotech company. Iovance ...

These top robo-advisors charge low fees but still ... Here is a list of our partners and here's how we make money. The investing information provided on this page is for educational purposes ...

Is immortality achievable? With longevity science booming, you might make it to age 150 — but your portfolio might not.

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

China's commitment to foster innovation and advance high-standard opening-up has provided global pharmaceutical companies ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...

Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has approved an amendment to its previously disclosed limited duration ...

President Trump said the company has been selected to build what may turn out to be the most expensive fighter in history. Johnson & Johnson said it is increasing U.S investments to more than $55 ...